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Abstract
Background: Herpes simplex virus type 1 (HSV1), a member of the alphaherpesvirinae, can cause recurrent facial
lesions and encephalitis. Two membrane envelopment processes, one at the inner nuclear membrane and a
second at cytoplasmic membranes are crucial for a productive viral infection. Depending on the subfamily,
herpesviruses encode more than 11 different transmembrane proteins including members of the tail-anchored
protein family. HSV1 encodes three tail-anchored proteins pUL34, pUL56 and pUS9 characterized by a single
hydrophobic region positioned at their C-terminal end that needs to be released from the ribosome prior to
posttranslational membrane insertion. Asna1/TRC40 is an ATPase that targets tail-anchored proteins to the
endoplasmic reticulum in a receptor-dependent manner. Cell biological data point to a critical and general role of
Asna1/TRC40 in tail-anchored protein biogenesis. With this study, we aimed to determine the importance of the
tail-anchored insertion machinery for HSV1 infection.
Methods: To determine protein-protein interactions, the yeast-two hybrid system was applied. Asna1/TRC40 was
depleted using RNA interference. Transient transfection and virus infection experiments followed by indirect
immunofluorescence analysis were applied to analyse the localization of viral proteins as well as the impact of
Asna1/TRC40 depletion on virus infection.
Results: All HSV1 tail-anchored proteins specifically bound to Asna1/TRC40 but independently localized to their target
membranes. While non-essential for cell viability, Asna1/TRC40 is required for efficient HSV1 replication. We show that
early events of the replication cycle like virion entry and overall viral gene expression were unaffected by depletion of
Asna1/TRC40. Furthermore, equal amounts of infectious virions were formed and remained cell-associated. This
indicated that both nuclear egress of capsids that requires the essential tail-anchored protein pUL34, and secondary
envelopment to form infectious virions were successfully completed. Despite large part of the virus life cycle
proceeding normally, viral propagation was more than 10 fold reduced. We show that depletion of Asna1/TRC40
specifically affected a step late in infection during release of infectious virions to the extracellular milieu.
Conclusions: Asna1/TRC40 is required at a late step of herpesviral infection for efficient release of mature virions to the
extracellular milieu. This study reveals novel tools to decipher exocytosis of newly formed virions as well as hitherto
unknown cellular targets for antiviral therapy.
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Background
Herpesviruses have evolved a life cycle that strongly
depends on two membrane-envelopment processes, one
at the inner nuclear membrane (INM) called primary
envelopment, and another at cytoplasmic membranes
called secondary envelopment, both of which are crucial
for a productive viral infection [1, 2]. Depending on the
subfamily, herpesviruses encode more than 11 different
transmembrane proteins involved in various aspects of
the individual viral life cycle.
Tail-anchored (TA) proteins represent a specific class
of transmembrane proteins characterized by a single
transmembrane domain (TMD) positioned at its very C-
terminal end. Thus, the hydrophobic region of a TA pro-
tein remains associated with the ribosomal tunnel until
translation is complete [3–6]. This requires that TA pro-
teins are released from the ribosome prior to their post-
translational insertion into various target membranes.
The identification of the TMD recognition complex of
40 kDa (TRC40) also known as Asna1 provided a major
breakthrough in understanding the TA protein biogen-
esis. Asna1/TRC40 is an ATPase conserved in many
species. It captures a TA protein following its ribosomal
translation and together with several other components
delivers it to a receptor of the endoplasmic reticulum
(ER). Recent biochemical and structural analysis have
further elucidated the mechanism of membrane inser-
tion of TA proteins. The ATP-bound dimer of Asna1/
TRC40 or its orthologs form a hydrophobic groove that
accommodates the TMD of TA proteins. The resulting
Asna1/TRC40-TA protein complex is then recruited to
the ER receptor resulting in release of the TA protein
and membrane insertion, a process that may require
ATP hydrolysis.
Like all TA proteins, the HSV1 TA proteins pUL34,
pUL56 and pUS9 are characterized by a cytoplasmic do-
main, a single C-terminal transmembrane domain (TMD)
and a short luminal extension (Fig. 1a). HSV1 pUL34 is a
protein conserved throughout the herpesvirus family ([7];
and references therein). Both its cyto-/nucleoplasmically
exposed N-terminal domain (residues 1–252) and its C-
terminal TMD (residues 252–272) are essential for viral
replication [8–10]. Posttranslational membrane insertion
of pUL34 occurs in the cytoplasm and thus prior to its
targeting to the INM [7]. There, pUL34 associates with
the nucleocapsid-bound pUL31 for subsequent primary
envelopment and egress of capsids to the cytoplasm [7].
The other two HSV1 TA proteins, pUL56 and pUS9,
are non-essential and specific for alpha-herpesviruses
([11, 12]; and references therein). pUL56 is composed of
a cytoplasmic domain (residues 1–211) followed by a
hydrophobic region (residues 211–231) and a short
luminal domain (Fig. 1a). In pUS9, a short N-terminal
domain (residues 1–69) is followed by a hydrophobic
domain between residues 69–89. Both pUL56 and pUS9
localize to the trans Golgi network (TGN) and are
integrated into mature virions during secondary en-
velopment [13].
Many herpesviral functions have been analysed in great
detail while our knowledge of virus-host interactions and
their importance for viral replication is far from complete.
With this study we focus on the biogenesis of tail-
anchored (TA) proteins and its importance for herpesviral
infection. Upon knockdown of Asna1/TRC40, large part
of the viral infection cycle proceeds normally and infec-
tious virions are formed, their release to the extracellular
milieu late in infection however is delayed. Together our
data suggest that efficient transport of infectious virions
along the secretory pathway requires Asna1 and thus the
TA insertion machinery.
Methods
Cells, yeast 2-hybrid assay and general cloning
HeLa (ATCC CCL-2) and Vero cells (ATCC CRL-1587)
were grown in DMEM containing 10 % FCS. Yeast 2-hy-
brid (Y2H) analysis was done as described [14]. The
UL34, UL45, UL56 and US9 genes previously cloned into
the entry vector pDONR207 [15] were transferred
into the Gateway compatible Y2H bait vector
pGBKT7-DBD and/or the mammalian expression vec-
tor pCR3-N-myc according to the manufacturer’s
protocol (Invitrogen). The human Asna1/TRC40 gene
previously cloned into the pDONR223 vector was
transferred to the Gateway compatible Y2H prey
vector pGADT7-AD according to the manufacturer’s
protocol (Invitrogen).
Viruses
HSV1(F) (provided by B. Roizman, University of Chi-
cago, USA) was used for infection experiments. The
strain HSV1(17+)lox (provided by B. Sodeik, Hannover
Medical School, Germany) was used as PCR template.
HSV1 propagation and virus growth curves were
performed as described [14]. To monitor infection, Vero
cells were infected with HSV1(F) at the indicated MOI.
Cell lysates were prepared at the indicated times post
infection and analysed by Western blotting using pri-
mary antibodies to the immediate early proteins ICP0
(anti-ICP0, Santa Cruz) and ICP27 (anti-ICP27, Virusys),
to the early protein gB (anti-Glykoprotein B, Santa Cruz)
and to the late proteins VP5 (anti-ICP5 (VP5), Abcam)
and pUL34 [9] followed by secondary antibodies conju-
gated to POX. Antibodies specific to β-actin (Abcam)
were used as control.
Indirect immunofluorescence microscopy
Indirect immunofluorescence (IF) analysis of transfected
or infected cells was done as described [14]. For plasmid
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transfection, the Effectene Transfection Reagent was
used. For virus infection, HeLa cells were infected at the
indicated MOI. In infected cells, binding of antibodies to
the HSV1 Fc-receptor like proteins gE/gI was blocked
overnight at 4 °C with human IgG (200 μg/ml) and 10 %
FCS in PBS [16]. The mouse monoclonal antibodies
anti-myc [9E10] (Santa Cruz), anti-ICP8 (provided by R.
Heilbronn, Charité Universitätsmedizin Berlin CCM,
Berlin, Germany), anti-Asna1/TRC40 ([M03], Klon 2H3
Abnova) and rabbit polyclonal antibodies anti-pUL34
[9], anti-Calreticulin (Sigma), and anti-Giantin (Abcam)




























Fig. 1 HSV1 encodes three tail-anchored proteins that interact with Asna1/TRC40. a Schematic diagrams show the domain organization of
pUL34, pUL56 and pUS9. The transmembrane domain (TMD) of pUL34 (residues 252–272), pUL56 (residues 211–231) and pUS9 (residues 69–89)
and the hydrophobicity plots generated by TMpred (http://embnet.vital-it.ch/software/TMPRED_form.html) are depicted. b The yeast two-hybrid
(Y2H) system was used to analyse the interaction of Asna1 and the HSV1 encoded tail-anchored (TA) proteins pUL34, pUL56 and pUS9. pUL45, a
type II membrane protein with an N-terminal transmembrane protein was used as control. Asna1 fused to the Gal4 activation domain (AD) was
tested for interaction with pUL34, pUL56, pUS9 and pUL45 fused to the Gal4 DNA-binding domain (DBD). Interaction of proteins is indicated by
transcriptional activation of the HIS3 reporter gene enabling growth (black squares) or no growth (grey squares) of yeast cells on selective media.
c To determine the subcellular distribution of Asna1/TRC40 during HSV1 infection, HeLa cells were mock treated or infected with HSV1(F) at an
MOI of 1 for 12 h followed by IF analysis using Asna1/TRC40- and Calreticulin-specific antibodies followed by secondary reagents. Nuclei were
visualized by DAPI staining
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mouse antibodies coupled to Alexa488 or Alexa594 (all
Invitrogen) were used as secondary reagents. Cells were
examined using a Leica confocal laser scanning micro-
scopes TCS SP5 and LSM710. Images were recorded
using the Leica Application Suite AF6000 Software and
processed using Adobe Photoshop.
SiRNA transfection
Gene silencing was essentially done as described [17].
Briefly, siRNAs (20 nM; GE Dharmacon), 150 μl of
HBSS, and 1,5 μl of transfection reagent were mixed and
added to HeLa cells in DMEM with 5 % FCS seeded in
12-well plates. Efficiency of RNAi was monitored by
Western blotting using mouse monoclonal antibodies to
Asna1/TRC40 ([M03], Klon 2H3 Abnova) and poly-
clonal goat anti-Lamin B (Santa Cruz) to control for
loading. The siRNA duplexes used for Asna1/TRC40
knockdown and as controls (Ctrl) are shown in Table 1.
Viral infection was generally performed 48 h (h) after
siRNA treatment. Infectious virions were quantified by
removing aliquots of medium and of infected cells at
various time points followed by plaque assay on Vero
cells [14]. To determine genome copy/pfu ratios of
virions released from cells, HeLa cells were treated with
Asna1/TRC40 specific or ctrl siRNA followed by infec-
tion with HSV1(F) for 30 h. Realtime quantitative PCR
using HSV1 specific primers were used to determine the
genome copies, plaque assays were performed as
described [14].
Results
HSV1 encodes three tail-anchored proteins that interact
with Asna1/TRC40
HSV1 encodes three TA proteins, called pUL34, pUL56
and pUS9. Hydrophobicity plots show that pUL34, an
essential protein conserved throughout the herpesviral
family, contains a transmembrane domain (TMD) between
residues 252–272 required for nuclear egress (Fig. 1a; [9]).
Two other TA proteins, pUL56 and pUS9, that are non-
essential and specific for alpha-herpesviruses, carry a TMD
between residues 211–231 and 69–89, respectively (Fig. 1a).
To determine whether pUL34, pUL56 and pUS9 inter-
act with Asna1/TRC40, the yeast 2-hybrid (Y2H) system
was applied. Asna1/TRC40 fused to the Gal4 activation
domain (AD) was tested for interaction with pUL34,
pUL56 and pUS9 fused to the Gal4 DNA-binding
domain (DBD). pUL45, that carries an N-terminal TMD
co-translationally integrated into membranes by an
Asna1/TRC40-independent mechanism, was used as
control. Interaction of proteins was reported by growth of
yeast cells on selective media. While DBD-pUL34, -pUL56
and -pUS9 co-expressed with AD-Asna1/TRC40 allowed
for growth of yeast cells, this was not the case for co-ex-
pression of DBD-pUL45 and AD-Asna1/TRC40 (Fig. 1b).
We thus conclude that all three TA proteins of HSV1 spe-
cifically interacted with Asna1/TRC40 supporting its func-
tion in posttranslational membrane insertion of these viral
proteins.
To analyse the subcellular distribution of Asna1/
TRC40 in presence and absence of HSV1 infection,
HeLa cells were mock treated or infected with HSV1(F)
for 12 h and subsequently processed for IF. Infected cells
were readily identified based on their marginalized chro-
matin as revealed by DAPI staining (Fig. 1c). Both in
noninfected and infected cells, Asna1/TRC40 showed a
pancellular distribution and significantly co-localized
with the ER marker Calreticulin (Fig. 1c) suggesting that
its distribution is essentially unaltered during HSV1
infection (Fig. 1c).
Targeting and membrane insertion of HSV1 pUL34,
pUL56 and pUS9 occur independent of Asna1/TRC40
In absence of other viral proteins, pUL34 is targeted
to the ER and the nuclear periphery, whereas pUL56
and pUS9 are located to the trans Golgi network
(TGN). To determine whether Asna1/TRC40 is re-
quired for proper membrane targeting of the HSV1
TA proteins, HeLa cells were transfected for 48 h
with Asna1/TRC40 specific or control (ctrl) siRNA.
Knockdown of Asna1/TRC40 was highly efficient as
shown by Western blotting (Fig. 2a). Interestingly, de-
pletion of Asna1/TRC40 did not affect cell viability of
Hela cells (data not shown).
RNAi treated cells were then transfected with plas-
mids encoding myc-tagged TA proteins and 20 h later
analysed by IF using monoclonal anti-myc antibodies.
Calreticulin or Giantin were used as markers of the
ER and the TGN, respectively. pUL34 showed a reticular
subcellular distribution and co-localized with the ER
marker Calreticulin consistent with its localization to the
ER and the nuclear periphery whether the cells were
treated with Asna1/TRC40 specific or ctrl siRNA (Fig. 2b,
left panel). pUL56 and pUS9 both located to the TGN as
indicated by their co-localization with the TGN marker
Giantin (Fig. 2b, middle and right panel). In Asna1
depleted cells, a certain amount of pUS9 was found in a
perinuclear region suggesting that membrane insertion of
pUS9 is influenced by the absence of Asna1. To summarize,
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all HSV1 TA proteins seemed to efficiently reach their tar-
get membranes irrespective of the presence or absence of
Asna1/TRC40.
Asna1/TRC40 is dispensable for virion entry and gene
expression during HSV1 infection
To determine whether Asna1/TRC40 is required for the
herpesviral life cycle, Asna1/TRC40 knockdown was per-
formed and monitored as shown before (Fig. 2a). Then,
siRNA treated HeLa cells were infected with HSV1 at an
MOI of 0.5 for 4 h (Fig. 3a). ICP0 expression was ana-
lysed as indirect means of viral entry. IF analysis
revealed that 20 % and 19 % of the cells treated with
ctrl- and Asna1/TRC40-specific siRNAs, respectively,
were infected by HSV1(F).
A time course experiment to detect viral proteins of all
kinetic classes was performed. HeLa cells were first
treated with Asna1/TRC40 or ctrl siRNA for 48 h and
subsequently infected with HSV1 at an MOI of 1. Cell
lysates were prepared at the indicated time-points and
probed with antibodies specific to the immediate early
regulators ICP0 and ICP27, to glycoprotein gB, to the
nuclear egress protein pUL34 and the major capsid pro-
tein ICP5 (VP5). β-Actin-specific antibodies were used to
control for equal loading of cell samples (Fig. 3b). The
transcriptional regulators ICP0 and ICP27 were detected
2 h post infection (h.p.i.), glycoprotein gB and the nuclear
egress protein pUL34 appeared 6 h.p.i., while the major
capsid protein ICP5 was detected 8 h.p.i.. Taken together,
we found that Asna1/TRC40 is not required for virion

















































Fig. 2 Targeting and membrane insertion of HSV1 pUL34, pUL56 and pUS9 occur independent of Asna1/TRC40. a To determine the effect of
Asna1/TRC40 depletion on cell growth, HeLa cells were transfected with Asna1/TRC40 specific or control (ctrl) siRNA for 48 h. Gene knockdown
was monitored by Western blotting using Asna1/TRC40 and Lamin B specific antibodies followed by secondary reagents. While efficient knock-down
was achieved, cell viability was normal indicating that Asna1/TRC40 silencing did not affect cellular growth. b To determine whether the HSV1 TA
proteins require the Asna1/TRC40 mediated pathway for localization to their target membrane, Asna1/TRC40 knockdown was performed in HeLa cells.
Subsequently, cells were transfected with plasmids encoding myc-tagged TA proteins and 20 h later analysed by IF using monoclonal anti-myc and
polyclonal anti-Calreticulin or anti-Giantin antibodies followed by secondary reagents. Nuclei were visualized by DAPI staining
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Targeting of pUL34 to the nuclear envelope during
infection is independent of Asna1/TRC40
HSV1 pUL34 is essential with a conserved function in
nuclear egress of capsids. To determine whether Asna1/
TRC40 is required for pUL34 biogenesis in the viral con-
text, RNAi was performed as described (Figs. 2a and 4a).
Subsequently, HeLa cells were infected with HSV1 at an
MOI of 1 for 12 h and subsequently processed for IF
(Fig. 4b and c). Antibodies specific to pUL34 (Fig. 4b) and
Lamin B (Fig. 4c) showed that both proteins were exclu-
sively located to the nuclear envelope. Furthermore, intra-
nuclear replication centers formed normally, as revealed by
ICP8-specific antibodies (Fig. 4b and c). Thus, we conclude
that pUL34 membrane insertion and targeting to the INM,
a prerequisite for NEC formation and capsid nuclear egress,
proceeds normally in absence of Asna1/TRC40.
Asna1/TRC40 is required late in infection for efficient
release of infectious virions from the cell
To determine the overall effect of Asna1/TRC40 knock-
down on the outcome of an HSV1 infection, Asna1/TRC40
depleted HeLa cells or ctrl cells were infected with HSV1 at
an MOI of 0.1. At the indicated time points, medium and
infected cells were harvested separately and analysed for
the presence of infectious virions using plaque assays. Equal
amounts of infectious virions were formed and remained
cell-associated whether cells were treated with Asna1/
TRC40 specific or ctrl siRNA (Fig. 5a). In contrast, about
10 times less infectious virions were released to the culture
medium upon Asna1/TRC40 depletion. To determine the
genome copy/pfu ratio of virus released 30 h.p.i. from the
infected cells, realtime quantitative PCR was performed.
Virions released from Asna1 siRNA treated cells showed
reduced amounts of genomes as well as plaque forming
units compared to the ctrl treated cells. In either case
however, their genome copy/pfu ratio was comparable indi-
cating that virions released to the extracellular milieu were
similar in infectivity (Fig. 5b). Thus, although not essential
for cellular growth and formation of infectious virions,
Asna1/TRC40 is required for release of mature virions





























Fig. 3 Asna1/TRC40 is dispensable for virion entry and gene expression during HSV1 infection. a To determine the importance of Asna1/TRC40
for entry and early gene expression of HSV1, HeLa cells were transfected with Asna1/TRC40 specific or control (ctrl) siRNA for 48 h. Silencing was
monitored as described in Fig. 2a (inset). Subsequently, cells were infected with HSV1(F) at an MOI of 0.5 for 4 h and analysed by IF using
monoclonal anti-ICP0 antibody followed by secondary reagents. Nuclei were visualized by DAPI staining. A total of 700 cells of either cell type
was analysed. b To determine whether Asna1/TRC40 is required for overall viral gene expression, cells treated with siRNA for 48 h were subsequently
infected with HSV1 at an MOI of 5, harvested at the indicated times post infection and analysed by Western blotting using ICP0, ICP27, glycoprotein
B (gB), pUL34 and VP5 (ICP5), and specific antibodies followed by secondary reagents. For control, β-actin specific antibodies were used
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Discussion
Asna1/TRC40 plays a central role during TA protein
biogenesis by binding to TMDs of newly synthesized TA
proteins and targeting them to the ER receptor for
subsequent membrane insertion [3–6]. While most data
on Asna1/TRC40-mediated TA protein biogenesis are
based on in vitro data, we show here that in vivo, a
highly efficient knockdown of Asna1/TRC40 does not
interfere with cell growth. Thus, Asna1/TRC40 seems to
be non-essential for cell viability under normal condi-
tions. This is surprising considering the many function-
ally important TA host proteins [18], but consistent with
the finding that components of the TA insertion machin-
ery are non-essential in yeast cells unless additional stress
is present [5]. Pathways redundant with Asna1/TRC40 for
posttranslational membrane insertion may involve the
signal recognition particle SRP or the heat shock protein
dimers Hsc70/Hsp40 [19–21].
Despite Asna1/TRC40 being non-essential for cellular
life, our data show that it is important for efficient
herpesviral propagation. Large part of the herpesviral life
cycle including nuclear egress of capsids tolerates the
absence of Asna1/TRC40; viral morphogenesis is com-
parable to control treated cells giving rise to equal num-
bers of intracellular infectious virions. Interestingly,
however, a specific defect is observed at a very late step
of the viral life cycle during release of mature virions to










































Fig. 4 Targeting of pUL34 to the nuclear envelope during infection is independent of Asna1/TRC40. To determine the importance of Asna1/TRC40 for
localization of pUL34 to the nuclear envelope in the virus context, HeLa cells were transfected with Asna1/TRC40 specific and control (ctrl) siRNA for
48 h (a). HSV1(F) infection was then performed for 12 h at an MOI of 0.1 followed by IF analysis using rabbit anti-pUL34 antibodies (b) or goat anti-Lamin B
antibodies (c) in combination with mouse anti-ICP8 antibodies and secondary reagents. Nuclei were visualized by DAPI staining
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role of Asna1/TRC40 late in HSV1 infection required
for efficient cytoplasmic transport and/or release of
infectious virions.
Recent evidence supports a role of the constitutive
secretory pathway in delivering virus containing secretory
vesicles to sites of exocytosis at the plasmamembrane [22].
A role for Asna1/TRC40 orthologs in transport and
release/fusion of secretory vesicles is supported by studies
in yeast [23] and Caenorhabditis elegans (C. elegans) [24].
In the herpesviral context, Asna1/TRC40 depletion could
limit the amount of specific host TA proteins required at
the site of virion exocytosis. In this respect, the SNARE
proteins involved in various vesicular and membrane
fusion processes represent an important group of TA host
factors [18, 25, 26]. Indeed, depletion of the SNARE TA
protein Syntaxin 3 results in reduced release of infectious
Human cytomegalovirus (HCMV) virions [27]. Alterna-
tively, the highly productive virus infection may pose a
general stress on the TA insertion machinery thereby
overwhelming its capacity. We were unable to identify a
specific compartment where the virions accumulated in
absence of Asna1 (data not shown) suggesting that the
overall dynamic of virion release is hampered.
Our data show that all HSV1 encoded TA proteins
specifically bind to Asna1/TRC40 consistent with their
TMD hydrophobicity index ≥ 40 [4]. Despite its ability to
bind pUL34, Asna1/TRC40 is redundant for pUL34
localization and function. Both pUL56 and pUS9 effect-
ively reached their target membranes in absence of
Asna1/TRC40. However, a certain amount of pUS9 was
mislocalized upon isolated expression suggesting that
Asna1 modulates pUS9 membrane insertion. Since indi-
vidual TA proteins favor particular insertion factors [5],
it is quite possible that pUL56 and pUS9 differ from
pUL34 in their propensity to use Asna1/TRC40 for
membrane targeting. Unfortunately, detailed analysis of
pUL56 and pUS9 in the viral context is limited due to
the lack of specific antibodies.
How could a reduced membrane insertion of the viral
TA proteins pUL56 and pUS9 affect virion release to the
extracellular milieu? Exposed on the cytoplasmic face of
secretory vesicles, their N-terminal domains may inter-
act with kinesin motor proteins [12, 28] to shuttle the
vesicular content to sites of secondary envelopment.
This way, pUL56 and pUS9 could modulate the trans-
port of secretory vesicles containing infectious virions.
Interestingly, pUS9 was recently reported to be neces-
sary for anterograde transport of virions in neurons
([29]; and references therein). Thus, TA protein biogen-
esis may have a particular impact on herpesviral neuro-
pathology where long-distance axonal transport of virus
containing secretory vesicles is likely to occur.
Biogenesis of TA membrane proteins destined for the
INM is not well understood. Membrane insertion of the
viral TA protein pUL34 that occurs prior to its transport
to the INM [7] is essential for its function ([7, 9]; and
references therein). Thus, pUL34 can serve as a viral
reporter to gain insight into the biogenesis of TA pro-
teins associated with the INM. Asna1/TRC40 specifically
binds to pUL34 suggesting it supports membrane inser-
tion of the INM protein pUL34. A role of Asna1/TRC40
in INM biogenesis is also provided by data on Emerin, a
TA protein associated with Emery-Dreifuss muscular dys-
trophy [30]. Together these data indicate that biogenesis
of INM TA proteins engages Asna1/TRC40-dependent
and -independent pathways [9, 30].
Taken together, our data reveal a role of the TA protein
biogenesis during release of virions. Asna1/TRC40 deple-





























Fig. 5 Asna1/TRC40 is required late in infection for efficient release of
infectious virions from the cell. a To analyse the growth properties of
HSV1 on Asna1/TRC40 depleted cells, HeLa cells were first transfected
with Asna1/TRC40 specific or control (ctrl) siRNA for 48 h. Silencing was
monitored as described in Fig. 2a (inset Fig. 5a). Subsequently, HeLa
cells were infected with HSV1 at an MOI of 0.1. Cells and cell
supernatants were harvested at the indicated time points. Virions
present in cells or in the extracellular milieu were titrated by plaque
assays on Vero cells in triplicates. b Genome copy/pfu ratio was
determined for virions released from siRNA treated cells at 30 h.p.i.
using plaque assays and realtime quantitative PCR
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process, a decisive step for virus spread. Since Asna1/
TRC40 knockdown preferentially perturbs virus replica-
tion while cellular growth remains unaffected, analysis of
TA protein biogenesis may reveal antiviral targets to in-
hibit virus propagation.
Conclusions
■ The TA protein insertion factor Asna1/TRC40 is
nonessential.
■ HSV1 encodes three tail-anchored proteins pUL34,
pUL56 and pUS9.
■ All HSV1 TA proteins specifically bind to Asna1/
TRC40.
■ Asna1/TRC40 is required for efficient HSV1
replication.
■ Asna1/TRC40 is redundant for nuclear egress of
capsids.
■ Depletion of Asna1/TRC40 results in a defect late in
herpesviral infection during release of infectious
virions.
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